The latest Omicron variant, BA.2.12.1, is on the rise in the American Northeast. Here we describe what may be the next catalyst for infections in the US and worldwide.
Category: pharma & healthcare
STING: It Takes Two To Tango
A new discovery uncovered a previously hidden binding site on a key immune protein known as STING that may enhance protection against infection. Knowing when to activate or inhibit this protein may be the key to controlling the widespread inflammatory …
SARS-CoV-2 Infection Of Monocytes Triggers Inflammation
Hyper-inflammation is a hallmark of severe Covid-19. New research shines a light onto one of the potential causes: infection of monocytes and macrophages.
New Members Of The Omicron Family Of Viruses: BA.2.12.1, BA.4, And BA.5
New members of the Omicron family continue to emerge. Here we describe descendants of the highly transmissible BA.2 tree.
Telemedicine Fails To Counter Healthcare Disparities During The Pandemic
A new study suggests that African Americans and Hispanic people were less likely than white people to use telemedicine during the first year of the pandemic.
Six Ways Fluvoxamine May Act To Prevent Severe Covid-19
Fluvoxamine has the potential to reduce the chance of progression to severe Covid-19. Here we describe the mechanisms that enable this ability.
SARS-CoV-2 Actively Infects And Kills Lymphoid Cells
A recent paper published in the journal Nature describes how SARS-CoV-2 infection induces a serious medical condition called lymphopenia by directly attacking and killing our immune T cells.
New Analysis Shows Fluvoxamine Has The Potential To Reduce Covid-19 Hospitalizations By More Than 90%
There is an ever-expanding need for SARS-CoV-2 antivirals. A recent analysis suggests fluvoxamine may greatly reduce the risk of hospitalization in Covid patients.
Remdesivir Resistance Reported Upon Treatment Of An Immunocompromised Patient
One of the questions that arises with any single drug treatment of an RNA virus is the level of resistance. Remdesivir has been approved as a stand-alone therapy for the treatment and prevention of COVID-19.
New Research Provides Hope In The Search For A Respiratory Syncytial Virus Vaccine- Part I
Respiratory syncytial virus is one of the leading causes of death for infants globally, and a safe vaccine is badly needed.
